Comparison of the Effect of Endurance and Speed Training Session on Plasma ANP in Male Athletic Students in Yazd

Subject Areas : Journal of Animal Biology

Mohammad Sadegh Zare ¹ , Tahereh Bagherpoor ² , Nematollah Nemati ³

1 - Department of Sport Science and Physical Education, Damghan Branch, Islamic Azad University, Damghan, Iran
2 - Department of Sport Science and Physical Education, Damghan Branch, Islamic Azad University, Damghan, Iran
3 - Department of Sport Science and Physical Education, Damghan Branch, Islamic Azad University, Damghan, Iran

Received: 2020-08-12 Accepted : 2020-12-17 Published : 2021-05-22

Keywords: Plasma ANP, Endurance and Speed Activity, Male Athletic Students,

Abstract :

The ANP is a cardiac neutrodiortic peptide which is secreted from the granules in atrial muscle cells during atrial expansion which helps balance the body's fluids by affecting the kidney. Studies have linked this hormone to cardiovascular disease. This study aimed to compare the effect of one session of endurance and speed training on the ANP in male athlete men. For this purpose, 90 male athletes were randomly selected and divided into three groups of endurance, speed, and control. Third, the heart rate was reduced, and they ran. Blood samples were taken 10 minutes before and 10 minutes after the exercise to measure plasma ANP. The results showed that one session of endurance and speed activity significantly increased the plasma ANP levels compared to the pre-test (p < 0.05). There was training (p < 0.05). However, the difference between the endurance and speed groups was not significant (p < 0.05). Consequently, it can be stated that a session of endurance and speed activity increases the plasma ANP of athletic students, and there is no difference between the effect of endurance and speed on ANP increase.

References:

1. Alimohammadian M., Rouzbahani M. 2014. NT-proBNP; the latest heart failure biomarker. Tehran University of Medical Sciences; 36)38(: 96-98 (In Persian)


2. Basile J. 2002. Hypertension in the elderly: a review of the importance of systolic blood pressure elevation. THE Jornal of Clinical Hypertension, 4: 108-119


3. Bentzen H., Pedersen R.S., Nyvad O.,  Pedersen  E. 2004. Effect of exercise on natriuretic peptides in plasma and urinein chronic heart failure. International Journal of Cardiology, 93(2-3):121-130.


4. Birjandi P., SabetJo M., Hedayati M. 2015. The effect of intense intermittent exercise and L-arginine supplementation on serum levels of fibroblast growth factor 21 and atrial peptide excreting sodium in overweight and obese young men, Scientific Journal of Birjand University of Medical Sciences. 23)3(: 212-221. (In Persian)


5. Braith R.W., Welsch M., Feigenbaum M., Kluess H., Pepine C. 2008.  Neuroendocrine activation in heart failure ismodified by endurance exercise training. Journal of the American College of Cardiology, 34: 1170-1175.


6. Dbold A. 1982. Tissue fractionation studies on the relationship between an atrial natriuretic factor and specific atrial granules. Can Journal of Physiology and Pharmacology, 60: 324-330.


7. Domingo P., Jordi C., 2015. Natriuretic peptides and their therapeutic potential in heart failure treatment. Revista Española de Cardiología, 65(7): 67-81.


8. Domingo A., Pascual F., Casademont J., Jose´ Marı´a L., Pascual P., Antoni Bayes G., Ordonez llanos J. 2016. Natriuretic peptides: consensus call for use. Revista Española de Cardiología, 69(9):817–819.


9. Felker G.M., Whellan D., Kraus W.E., Clare R., Zannad F., Donahue M., Adams K., McKelvie R.L., Piña I. 2009. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-Action) study. American Heart Journal, 158: 37-44.


10. Fukuda Y., Hirata Y., Taketani S., Kojima T., Oikawa S., Nakazato H., Hiroshi I., Nitta M., Adachi, S. 1989. Endothelin stimulates accumulations for cellular atrial natriuretic peptide and its messenger RNA in rat cardiocytes. Bio Biophys Res Commun. 164: 1431-1436.


11. Geny B., Saini J., Mettauer B., Lampert E, Piquard F., Follenius M., Epailly E., Schnedecker B., 1996. Effect of short-term endurance training on exercise capacity, haemodynamics and atrial natriuretic peptide secretion in heart transplant recipients. European Journal of Applied Physiology and Occupational Physiology, 73: 259-266.


12. Hager A., Christov F., Hess J. 2012. Increase in N-terminus-pro-B-type natriuretic peptide during exercise of patients with univentricular heart after a total cavopulmonary connection. Pediatric Cardiology, 33(5):764-769


13. Hakimi M., Ali-Mohammadi M., Baghaiee B., Siahkouhian M., Bolboli L. 2016. Comparing the effects of 12weeks of resistance and endurance training on ANP, Endothelin-1, Apeline and blood pressure in hypertensive middle-age men. Journal of Urumia University of Medical Sciences, 26(12): 1080-1089. (In Persian)


14. Lafontan M., Moro C., Sengenes C., Galitzky J., Crampes F., Berlan M. 2005. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arteriosclerosis, Thrombosis, and Vascular Biology, 25)20(: 32-42.


15. Mair J. 2008. Biochemistry of B-type natriuretic peptide? where are we now? Clinical Chemistry and Laboratory Medicine, 46(11):1507-1514.


16. Malekzadeh S. 1987. Cardiac neutrodiortic peptide (ANP). Tehran, Miqat Publication, First Edition, (1): 232-238. (In Persian)


17. McKeever K.H., Malinowski K. 1999. Endocrine response to exercise in young and old horses. Equine Veterinary Journal, 31(30): 561-566.


18. Miller T.D., Rogers P.J., Bauer B.A., Burnett J.C., Bailey K.A., Bove A.A. 1990. What stimulates atrial natriuretic factor release during exercise. Journal of Laboratory and Clinical Medicine, 116: 487-491.


19. Naghizadeh S., Ravasi A.A. 2014. The effect of resistance and sprint training on plasma ANP of non-athlete men. Journal of Sport Biosciences, 6(3):301-315. (In Persian)


20. Namdari M., Eatemadi A., Negahdari B. 2016. Natriuretic peptides and their therapeutic potential in heart failure treatment: An updated review. Cell Molecular Biology, 62(11):1-7. (In Persian)


21. Naseri, A. Nikseresht, A. 1398. Comparison of acute response of serum atrial natriuretic peptide to severe anaerobic activity in healthy male and female athletes, Pars Journal of Medical Sciences, 14)2(:9-14. (In Persian)


22. Niessner A., Ziegler S., Slany J., Billensteiner E., Woloszczuk W., Geyer G. 2003. Increases in plasma levels of atrial and brain natriuretic peptides after running a marathon: are their effects partly counterbalanced by adrenocortical steroids. European Journal of Endocrinology, 149)6(: 555-559.


23. Ohba Haruo, Takada Hideomi, Musha Haruki, Nagashima Junzo, Mori Narumi, Awaya Toru, Omiya Kazuto and Murayama Masahiro. (2001). "Effects of prolonged strenuous exercise on plasma levels of atrial natruiuretic peptide and brain natriuretic peptide in healthy men". American Heart Journal, 141(5): 56-76.


24. Ponikowski P., Voors A.D., Anker S.,  Bueno H., Cleland A., Coats A., Falk V.  2016. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37(27): 21-29.


25. Pruszczyk P., Kostrubiec M., Bochowicz A., Styczyński G., Szulc M., Kurzyna M., Fijałkowska A., Chlewicka I . 2003. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. European Respiration Journal, 22: 649-53.


26. Ranjbar A, Nematbakhsh M. 2003. Investigation thephysiologic Effects of ANP on mice who don’t receive ketoconazole. Feiz Journal, 24: 11-16. (In Persian)


27. Ravasi A., Kordi M., Naghizadeh S., 2011. The effect of one session endurance & speedy exercise on ANP plasma of student's sport men. Exerersise Biological Sciences Journal, 4: 125-138. (In Persian)


28. Sarraf zadegan. S. 2014. Research project to study the risk factors for cardiovascular disease in urban areas of Isfahan, Tehran: Ministry of Health and Medical Education, 13(5): 236-244. (In Persian)


29. Vesely D, Winters C, Sallman A. 1989. Prohormone atrial natriuretic peptides 1-30 and 31-67 increase in hyperthyroidism and decrease in hypothyroidism. American Journal of Medical Sciences, 297: 209-215.


30. Wada A., Tsutamoto T., Matsuda Y., Kinoshita M. 1994. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestiveheart failure using a specific antagonist for guanyl atecyclase-coupled receptors. Circulation, 89: 2232- 2240.